Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Insulet Corporation before investing.

In this article, we go over a few key elements for understanding Insulet Corporation’s stock price such as:

• Insulet Corporation’s current stock price and volume
• Why Insulet Corporation’s stock price changed recently
• Upgrades and downgrades for PODD from analysts
• PODD’s stock price momentum as measured by its relative strength

About Insulet Corporation (PODD)

Before we jump into Insulet Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Want to learn more about Insulet Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Insulet Corporation.

Insulet Corporation’s Stock Price as of Market Close

As of May 09, 2025, 12:47 PM, CST, Insulet Corporation’s stock price was $309.260.

Insulet Corporation is up 20.33% from its previous closing price of $257.000.

During the last market session, Insulet Corporation’s stock traded between $293.030 and $311.650. Currently, there are approximately 70.16 million shares outstanding for Insulet Corporation.

Insulet Corporation’s price-earnings (P/E) ratio is currently at 44.4, which is high compared to the Health Care Equipment & Supplies industry median of 32.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Insulet Corporation Stock Price History

Insulet Corporation’s (PODD) price is currently up 22.58% so far this month.

During the month of May, Insulet Corporation’s stock price has reached a high of $311.650 and a low of $248.400.

Over the last year, Insulet Corporation has hit prices as high as $289.460 and as low as $160.190. Year to date, Insulet Corporation’s stock is up 18.46%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Insulet Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 08, 2025, there were 0 analysts who downgraded Insulet Corporation’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Insulet Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Insulet Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Insulet Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Insulet Corporation (PODD) by visiting AAII Stock Evaluator.

Relative Price Strength of Insulet Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 08, 2025, Insulet Corporation has a weighted four-quarter relative price strength of 4.58%, which translates to a Momentum Score of 73 and is considered to be Strong.

Want to learn more about how Insulet Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Insulet Corporation Stock Price: Bottom Line

As of May 9, 2025, Insulet Corporation’s stock price is $309.260, which is up 20.33% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Insulet Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.